Knowledge, Attitudes and Practices on the Use of Antidiabetic Medications for Weight Loss: A Cross-Sectional Study in the Lebanese Population.

Endocrinology, diabetes & metabolism

Medical Treatments for Obesity: What Does the Future Have in Store?

The Journal of clinical endocrinology and metabolism

Safety Profile of Tirzepatide in Real-World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database.

Diabetes, obesity & metabolism

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.

Annals of internal medicine

GLP-1 Receptor Agonists and Fertility: What Is Known So Far?

JBRA assisted reproduction

[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2].

Revista medica de Chile

Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study.

Obesity pillars

Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review.

Acta diabetologica

The ultimate peptide cheatsheet. Here's every peptide worth knowing, sorted by what it does in your body: Fat loss: → AOD-9604 → 5-Amino-1MQ → Tesofensine → MOTS-c → Setmelanotide → LIPO-C: GLP-1 receptor agonists: → Semaglutide → Tirzepatide → Retatrutide →

🕵️With PCOS (polycystic ovary syndrome) being reclassified as PMOS (polyendocrine metabolic syndrome), thought I’d review the current PCOS and infertility related trials currently recruiting. (Also, a friend was asking!) Many women report meaningful improvements with PCOS

Who the July 23–24 peptide panel is made up of might be the biggest tell we have that the peptide bull market is just getting started. Reuters reported that 7 of the 14 panelists have ties to peptide clinics or peptide therapy businesses. If that’s not a sign that a handful of

We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like

We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like

Three compounds in the typical peptide conversation are actually FDA-approved drugs semaglutide, tirzepatide, tesamorelin. The rest are not approved. The menu won't tell you which is which.

Here’s a quick breakdown of the key differences between general peptides and Khavinson-style bioregulators: Peptides are short chains of amino acids (typically 2–50). They include hormones (insulin), growth factors (BPC-157, TB-500), signaling molecules (semaglutide), and many

🧬 The “Ozempic halo” is reshaping the peptide market — and not always safely. The success of semaglutide and tirzepatide has normalized self-injection, leading some consumers to assume that all peptides are credible and safe. But FDA-approved drugs and gray-market “research https://t.co/yamtWQY0Jb